Ultragenyx Pharmaceutical Inc
(LTS:0LIF)
$
51.134
0.686 (1.35%)
Market Cap: 4.70 Bil
Enterprise Value: 3.98 Bil
PE Ratio: 0
PB Ratio: 10.88
GF Score: 72/100 
Ultragenyx Pharmaceutical Inc at TD Cowen Health Care Conference Transcript
Mar 04, 2024 / 02:10PM GMT
Release Date Price:
$52.92
(-2.53%)
Yaron Benjamin Werber
TD Cowen, Research Division - MD & Senior Biotechnology Analyst
All right. Well, good morning, everybody, and thank you for joining us at the 44th Annual TD Cowen Healthcare Conference here in Boston. I'm Yaron Werber, on the biotech team, and it's a great pleasure to moderate this session with Ultragenyx, along with my colleague, Brendan Smith.
With us today, we have Eric Crombez, who is the Chief Medical Officer and EVP at Ultragenyx. Eric, good to see you.
Eric Crombez
Ultragenyx Pharmaceutical Inc. - Chief Medical Officer & Executive VP
Good to see you.
Yaron Benjamin Werber
TD Cowen, Research Division - MD & Senior Biotechnology Analyst
Thanks for joining us.
Questions & Answers
Yaron Benjamin Werber
TD Cowen, Research Division - MD & Senior Biotechnology Analyst
So lots going on from Ultragenyx this year. This is really going to be a year of pipeline, both Phase III pipeline and Phase sort of II pipeline
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers